RELIGRAST 300MCG INJECTION
RELIGRAST 300MCG INJECTION
Regular price
Rs. 179.00
Regular price
Rs. 179.00
Sale price
Unit price
per
Couldn't load pickup availability
Note: Only 7 units left in stock
-
Ordered
- - -
Order Ready
- - -
Delivered
RELIGRAST 300MCG INJECTION
Regular price
Rs. 179.00
Regular price
Rs. 179.00
Sale price
Unit price
per
About RELIGRAST 300MCG INJECTION
- RELIGRAST 300MCG INJECTION contains filgrastim, a white blood cell growth factor (granulocyte-colony stimulating factor). Approved by the FDA, it lowers the risk of febrile neutropenia (fever or infection with low WBC count) and shortens neutropenia duration (low white blood cell count) in non-myeloid cancer patients undergoing chemotherapy. It also elevates WBC count and reduces fever duration in individuals with acute myeloid leukemia.
- Furthermore, it is used in individuals undergoing bone marrow transplants and those with severe chronic neutropenia (low neutrophil count). RELIGRAST 300MCG INJECTION also prepares blood for leukapheresis (selective removal of blood cells). It enhances survival chances after exposure to harmful radiation levels, preventing severe bone marrow damage. Additional uses include reducing infection risk in advanced HIV infection patients. RELIGRAST is crucial in managing conditions associated with compromised immune systems.
- RELIGRAST 300MCG INJECTION belongs to the colony-stimulating factor medication class. It boosts white blood cell production, essential for fighting infections. Chemotherapy can significantly reduce WBC counts, weakening the body's defense against bacteria and increasing infection risk. Before use, inform your doctor about any history of liver disease, kidney problems, sickle cell anemia, or bone disease. Common side effects include fever, pain, rash, cough, shortness of breath, and nosebleed. Monitoring blood counts regularly during treatment is essential to assess the effectiveness and safety of the medication.
- It is vital to adhere to the prescribed dosage and schedule provided by your healthcare provider. Any deviations or concerns should be promptly discussed with your physician. Maintaining open communication with your healthcare team ensures the safe and effective use of RELIGRAST 300MCG INJECTION, optimizing your treatment outcomes and overall well-being during cancer therapy or other indicated conditions.
